LAVAL, Quebec, Nov. 19, 2018 /CNW/ -- Bausch Health
Companies Inc. (NYSE/TSX: BHC) today announced that the company
will participate in three upcoming investor conferences.
Joseph C. Papa, chairman and
chief executive officer, is scheduled to participate at the 30th
Annual Piper Jaffray Healthcare Conference in
New York on Nov. 27, 2018 at 10:30
a.m. ET.
Paul S. Herendeen, executive vice
president and chief financial officer, and Arthur J. Shannon, senior vice president and
head of Investor Relations and Communications, are scheduled to
participate at the Evercore ISI HealthconX Conference on
Nov. 28, 2018 in Boston at 3:30 p.m.
ET.
Paul S. Herendeen, executive vice
president and chief financial officer, and Arthur J. Shannon, senior vice president and
head of Investor Relations and Communications, are scheduled to
participate at the 2018 Citi Global Healthcare Conference on
Dec. 5, 2018 in New York at 8:45 a.m.
ET.
Live webcasts and audio archives of the events will be available
on the Investor Relations page of the Bausch Health Companies Inc.
web site at:
http://ir.bauschhealth.com/events-and-presentations/2018.
About Bausch Health
Bausch Health Companies Inc.
(NYSE/TSX: BHC) is a global company whose mission is to improve
people's lives with our health care products. We develop,
manufacture and market a range of pharmaceutical, medical device
and over-the-counter products, primarily in the therapeutic areas
of eye health, gastroenterology and dermatology. We are delivering
on our commitments as we build an innovative company dedicated to
advancing global health. More information can be found at
www.bauschhealth.com.
Investor
Contact:
|
Media
Contact:
|
Arthur
Shannon
|
Lainie
Keller
|
arthur.shannon@bauschhealth.com
|
lainie.keller@bauschhealth.com
|
(514)
856-3855
|
(908)
927-0617
|
(877) 281-6642 (toll
free)
|
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/bausch-health-announces-participation-in-upcoming-investor-conferences-300752803.html
SOURCE Bausch Health Companies Inc.